Literature DB >> 9794225

Characterization of an HPV-negative cell line (FR-CAR) derived from a cervical squamous intraepithelial lesion.

C van Haaften-Day1, B Rose, C Thompson, R Lukeis, P Russell.   

Abstract

A new cell line, FR-car, has been established from a biopsy of a low-grade human cervical squamous intraepithelial lesion (SIL). We confirmed the epithelial origin of the cells by keratin staining using polykeratin, AE1/AE3 and CAM 5.2 antibodies. Sixty percent to 80% of the cultured cells stained positive for proliferative cell nuclear antigen (PCNA) and Ki-67. There was no overexpression of p53. Karyotyping revealed that the cell line was hypodiploid with clonal abnormalities on chromosome 6 and 16. Sections of a biopsy adjacent to the lesion from which the culture was initiated tested positive for human papillomavirus (HPV) 18 DNA by the polymerase chain reaction, but cultured cells tested at several passages were HPV-negative by either type-specific or consensus PCRs. This HPV-negative SIL line may be useful in studies into the cell biology of dysplastic epithelium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794225     DOI: 10.1007/s11626-998-0069-y

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  28 in total

1.  Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma).

Authors:  C van Haaften-Day; P Russell; S Carr; L Wright
Journal:  In Vitro Cell Dev Biol       Date:  1988-10

2.  Properties of a non-tumorigenic human cervical keratinocyte cell line.

Authors:  M A Stanley; H M Browne; M Appleby; A C Minson
Journal:  Int J Cancer       Date:  1989-04-15       Impact factor: 7.396

3.  Fractionation of DNA fragments by polyethylene glycol induced precipitation.

Authors:  J T Lis
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  An in vitro study of ovarian atypical proliferating (borderline) serous tumors.

Authors:  C. van Haaften-Day; P. Russell; S. Davies; S. Brammah-Carr
Journal:  Int J Gynecol Cancer       Date:  1992-01       Impact factor: 3.437

5.  Expression of cell regulatory proteins in ovarian borderline tumors.

Authors:  C van Haaften-Day; P Russell; C M Boyer; B J Kerns; J R Wiener; D N Jensen; R C Bast; N F Hacker
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

6.  Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers.

Authors:  L M Tieben; J ter Schegget; R P Minnaar; J N Bouwes Bavinck; R J Berkhout; B J Vermeer; M F Jebbink; H L Smits
Journal:  J Virol Methods       Date:  1993-05       Impact factor: 2.014

7.  Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix.

Authors:  I Konishi; S Fujii; H Nonogaki; Y Nanbu; T Iwai; T Mori
Journal:  Cancer       Date:  1991-09-15       Impact factor: 6.860

8.  Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.

Authors:  M R Mullokandov; N G Kholodilov; N B Atkin; R D Burk; A B Johnson; H P Klinger
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

9.  Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation.

Authors:  M A Bedell; J B Hudson; T R Golub; M E Turyk; M Hosken; G D Wilbanks; L A Laimins
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium.

Authors:  M S Shurbaji; S K Brooks; T S Thurmond
Journal:  Am J Clin Pathol       Date:  1993-07       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.